Compare Adaptive Biotechnologies Corp (ADPT) vs NetEase Inc (NTES) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs NetEase Inc — how do they compare? Adaptive Biotechnologies Corp trades at $20.19 (market cap $3.33B), while NetEase Inc trades at $133.01 (market cap $83.83B). The key difference: NetEase Inc is far larger — about 25.2× Adaptive Biotechnologies Corp's market cap, and NetEase Inc pays a 2.31% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | NTES | |
|---|---|---|
Market Cap | $3.33B | $83.83B |
Sector | Health | Media |
52-Week High | $22.37 | $159.34 |
52-Week Low | $10.24 | $109.26 |
Enterprise Value | $3.19B | $60.31B |
Dividend Yield | — | 2.31% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About NetEase Inc
NetEase, which started on an internet portal service in 1997, is a leading online services provider in China. Its key services include online/mobile games, cloud music, media, advertising, email, live streaming, online education, and e-commerce. The company develops and operates some of the China's most popular PC client and mobile games, and it partners with global leading game developers, such as Blizzard Entertainment and Mojang (a Microsoft subsidiary).
Read more on NTES →
